Pharma / Biotech

FDA Approves Ivosidenib as First-Line Therapy for AML

The agency reviewed the application for ivosidenib using its Real-Time Oncology Review pilot program.

Source link

Related posts

Transfer of amoxicillin to suckling mink (Neovison vison) kits via the milk from dams treated orally or intra-muscularly.


The Transdermal Performance, Pharmacokinetics and Anti-inflammatory Pharmacodynamics Evaluation of Harmine-loaded Ethosomes.


AMNESTEEM (Isotretinoin) Capsule [Mylan Pharmaceuticals Inc.]


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World